New drug trial aims to improve blood flow for leg pain caused by PAD
NCT ID NCT06774040
Summary
This study aims to find a safe and effective dose of a new drug called Etrinabdione for people with peripheral arterial disease (PAD), which causes poor blood flow and pain in the legs. It will involve 30 adults with moderate to severe PAD who will take the drug twice daily for a year. The main goals are to check for side effects and see if the drug improves blood flow, walking ability, and quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERIAL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Universitario Reina Sofía
Córdoba, 14014, Spain
Conditions
Explore the condition pages connected to this study.